KLP Kapitalforvaltning’s iTeos Therapeutics ITOS Stock Holding History

KLP Kapitalforvaltning’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,400	Closed	-$552K	–	2193
2025 Q2	$552K	Buy	55,400 +16,500	+42%	+$133K	﹤0.01%	1319
2025 Q1	$232K	Hold	38,900	–	–	﹤0.01%	1679
2024 Q4	$299K	Buy	+38,900	New	+$334K	﹤0.01%	1654

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KLP Kapitalforvaltning's ITOS Position: Q3 2025 in Review

KLP Kapitalforvaltning sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 55,400 shares — an estimated $552K sold.

KLP Kapitalforvaltning first reported a position in ITOS in Q4 2024 and held it in 3 quarters. The position peaked at $552K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

KLP Kapitalforvaltning reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
KLP Kapitalforvaltning sold 55,400 iTeos Therapeutics shares in Q3 2025, an estimated $552K.
KLP Kapitalforvaltning first reported a position in iTeos Therapeutics in Q4 2024 and held it in 3 quarters.
KLP Kapitalforvaltning's iTeos Therapeutics position peaked at $552K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2025, filed 23 Oct 2025.